Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tina Pöttler"'
Autor:
Julia Kopanz, Bart Lagerwaard, Magdalena Beran, Jorien Veldwijk, Julia K. Mader, Tina Pöttler, Dietrich Tews, Diederick E. Grobbee, Mira G. P. Zuidgeest
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 11, Pp n/a-n/a (2024)
Abstract Decentralized clinical trials (DCTs), in which all or part of the trial activities are moved to the participants' immediate surroundings, promise to improve trial conduct. However, no evidence is available on what motivates people to partici
Externí odkaz:
https://doaj.org/article/0180adef2af0498e8648e17eeabe1dfd
Autor:
Katharina Secco, Petra Martina Baumann, Tina Pöttler, Felix Aberer, Monika Cigler, Hesham Elsayed, Clemens Martin Harer, Raimund Weitgasser, Ingrid Schütz-Fuhrmann, Julia Katharina Mader
Publikováno v:
Sensors, Vol 24, Iss 14, p 4514 (2024)
Objective: The aim of this analysis was to assess glycemic control before and during the coronavirus disease (COVID-19) pandemic. Methods: Data from 64 (main analysis) and 80 (sensitivity analysis) people with type 1 diabetes (T1D) using intermittent
Externí odkaz:
https://doaj.org/article/f262e74774b6402a9f5fb5d14a8f7804
Autor:
Daniel A. Hochfellner, Amra Simic, Marlene T. Taucher, Lea S. Sailer, Julia Kopanz, Tina Pöttler, Julia K. Mader
Publikováno v:
Biosensors, Vol 13, Iss 7, p 710 (2023)
We thank Dr. Freckmann et al. [...]
Externí odkaz:
https://doaj.org/article/922370f463aa4c149e19960e0742880d
Autor:
Laurenz T. Fischer, Daniel A. Hochfellner, Lisa Knoll, Tina Pöttler, Julia K. Mader, Felix Aberer
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-15 (2021)
Abstract Background The lipid-lowering and positive cardiovascular effect of proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors was shown in several studies, hence, they are more widely used in the lipid-lowering management of individua
Externí odkaz:
https://doaj.org/article/b766227e007947688d56f1ca6e73d137
Autor:
Julia K Mader, Felix Aberer, Kerstin Sarah Drechsler, Tina Pöttler, Katharina M Lichtenegger, Wolfgang Köle, Gerald Sendlhofer
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267570 (2022)
IntroductionDrug errors pose a major health hazard to a number of patient populations. However, patients with type 2 diabetes mellitus seem especially vulnerable to this risk as diabetes mellitus is usually concomitant with various comorbidities and
Externí odkaz:
https://doaj.org/article/74d6f50f1af44b9eac300bee43744d87
Autor:
Daniel A. Hochfellner, Amra Simic, Marlene T. Taucher, Lea S. Sailer, Julia Kopanz, Tina Pöttler, Julia K. Mader
Publikováno v:
Biosensors, Vol 12, Iss 2, p 106 (2022)
The aim of this study was to evaluate the accuracy and usability of a novel continuous glucose monitoring (CGM) system designed for needle-free insertion and reduced environmental impact. We assessed the sensor performance of two GlucoMen® Day CGM s
Externí odkaz:
https://doaj.org/article/9762cf9444534587bef074b47c5c73b3
Autor:
Daniela Ninaus, Tobias Stumpe, Matthias Heschel, Werner Regittnig, Thomas R. Pieber, Thomas Augustin, Tina Pöttler, Julia K. Mader, Andrea Groselj-Strele, Pernelle K. Schøndorff, Amra Simic
Publikováno v:
Diabetes, Obesity & Metabolism
Maintaining good glycemic control with the same infusion set for longer than three days may improve quality of life of insulin pump users. The aim of the present study was to assess the efficacy and safety of the novel, extended-wear infusion set ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc79012b6900f6d3b24dc102f0ca486
https://doi.org/10.1111/dom.14337
https://doi.org/10.1111/dom.14337
Autor:
Marlene T. Taucher, Lea S Sailer, Tina Pöttler, Amra Simic, Julia K Mader, Julia Kopanz, Daniel A. Hochfellner
Publikováno v:
Biosensors; Volume 12; Issue 2; Pages: 106
The aim of this study was to evaluate the accuracy and usability of a novel continuous glucose monitoring (CGM) system designed for needle-free insertion and reduced environmental impact. We assessed the sensor performance of two GlucoMen® Day CGM s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9012f5ff28cdfb7b1047a700d8fd9d8
Autor:
Julia K. Mader, Felix Aberer, Kerstin Sarah Drechsler, Tina Pöttler, Katharina M. Lichtenegger, Wolfgang Köle, Gerald Sendlhofer
Publikováno v:
PloS one. 17(4)
Introduction Drug errors pose a major health hazard to a number of patient populations. However, patients with type 2 diabetes mellitus seem especially vulnerable to this risk as diabetes mellitus is usually concomitant with various comorbidities and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6abca80570a1dfc63456aa3a75f6292
https://pubmed.ncbi.nlm.nih.gov/35482748
https://pubmed.ncbi.nlm.nih.gov/35482748
Autor:
Julia K Mader, Lisa Knoll, Felix Aberer, Laurenz T. Fischer, Daniel A. Hochfellner, Tina Pöttler
BackgroundThe lipid-lowering and positive cardiovascular effect of proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors was shown in several studies, hence, they are more widely used in the lipid-lowering management of patients with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fae71c43a38cf63e90f71d19945984cf
https://doi.org/10.21203/rs.3.rs-154495/v1
https://doi.org/10.21203/rs.3.rs-154495/v1
